Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MOH vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MOH
Molina Healthcare, Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$10.01B
5Y Perf.+3.4%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$330.28B
5Y Perf.+19.4%

MOH vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MOH logoMOH
UNH logoUNH
IndustryMedical - Healthcare PlansMedical - Healthcare Plans
Market Cap$10.01B$330.28B
Revenue (TTM)$45.08B$449.71B
Net Income (TTM)$188M$12.04B
Gross Margin9.6%18.8%
Operating Margin1.2%4.2%
Forward P/E37.3x19.9x
Total Debt$3.95B$78.39B
Cash & Equiv.$4.25B$24.36B

MOH vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MOH
UNH
StockMay 20May 26Return
Molina Healthcare, … (MOH)100103.4+3.4%
UnitedHealth Group … (UNH)100119.4+19.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: MOH vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 7 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
MOH
Molina Healthcare, Inc.
The Insurance Pick

MOH is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 323.6% 10Y total return vs UNH's 217.0%
  • Lower volatility, beta -0.04, Low D/E 97.1%, current ratio 1.69x
  • Beta -0.04, current ratio 1.69x
Best for: long-term compounding and sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
  • 11.8% revenue growth vs MOH's 11.7%
  • Lower P/E (19.9x vs 37.3x)
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUNH logoUNH11.8% revenue growth vs MOH's 11.7%
ValueUNH logoUNHLower P/E (19.9x vs 37.3x)
Quality / MarginsUNH logoUNHCombined ratio 1.0 vs MOH's 1.0 (lower = better underwriting)
Stability / SafetyUNH logoUNHLower D/E ratio (77.1% vs 97.1%)
DividendsUNH logoUNH2.4% yield; 25-year raise streak; the other pay no meaningful dividend
Momentum (1Y)UNH logoUNH-7.9% vs MOH's -39.9%
Efficiency (ROA)UNH logoUNH3.9% ROA vs MOH's 1.2%, ROIC 9.2% vs 17.4%

MOH vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MOHMolina Healthcare, Inc.
FY 2025
Medicaid Solutions Segment
74.7%$32.2B
Medicare
14.5%$6.2B
Marketplace
10.4%$4.5B
Other Segments
0.4%$177M
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

MOH vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGMOH

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 6 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 10.0x MOH's $45.1B. Profitability is closely matched — net margins range from 2.7% (UNH) to 0.4% (MOH). On growth, UNH holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMOH logoMOHMolina Healthcare…UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$45.1B$449.7B
EBITDAEarnings before interest/tax$710M$23.2B
Net IncomeAfter-tax profit$188M$12.0B
Free Cash FlowCash after capex$251M$19.7B
Gross MarginGross profit ÷ Revenue+9.6%+18.8%
Operating MarginEBIT ÷ Revenue+1.2%+4.2%
Net MarginNet income ÷ Revenue+0.4%+2.7%
FCF MarginFCF ÷ Revenue+0.6%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year-3.1%+2.0%
EPS Growth (YoY)Latest quarter vs prior year-95.0%+0.7%
UNH leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

MOH leads this category, winning 4 of 5 comparable metrics.

At 21.5x trailing earnings, MOH trades at a 22% valuation discount to UNH's 27.5x P/E. On an enterprise value basis, MOH's 10.0x EV/EBITDA is more attractive than UNH's 16.5x.

MetricMOH logoMOHMolina Healthcare…UNH logoUNHUnitedHealth Grou…
Market CapShares × price$10.0B$330.3B
Enterprise ValueMkt cap + debt − cash$9.7B$384.3B
Trailing P/EPrice ÷ TTM EPS21.54x27.50x
Forward P/EPrice ÷ next-FY EPS est.37.27x19.87x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple9.95x16.48x
Price / SalesMarket cap ÷ Revenue0.22x0.74x
Price / BookPrice ÷ Book value/share2.40x3.26x
Price / FCFMarket cap ÷ FCF20.55x
MOH leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 5 of 9 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $4 for MOH. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to MOH's 0.97x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs MOH's 4/9, reflecting solid financial health.

MetricMOH logoMOHMolina Healthcare…UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity+4.4%+11.5%
ROA (TTM)Return on assets+1.2%+3.9%
ROICReturn on invested capital+17.4%+9.2%
ROCEReturn on capital employed+9.8%+9.7%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.97x0.77x
Net DebtTotal debt minus cash-$298M$54.0B
Cash & Equiv.Liquid assets$4.2B$24.4B
Total DebtShort + long-term debt$4.0B$78.4B
Interest CoverageEBIT ÷ Interest expense2.12x4.71x
UNH leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

UNH leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in UNH five years ago would be worth $9,722 today (with dividends reinvested), compared to $7,307 for MOH. Over the past 12 months, UNH leads with a -7.9% total return vs MOH's -39.9%. The 3-year compound annual growth rate (CAGR) favors UNH at -7.7% vs MOH's -13.8% — a key indicator of consistent wealth creation.

MetricMOH logoMOHMolina Healthcare…UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date+7.7%+8.8%
1-Year ReturnPast 12 months-39.9%-7.9%
3-Year ReturnCumulative with dividends-35.8%-21.4%
5-Year ReturnCumulative with dividends-26.9%-2.8%
10-Year ReturnCumulative with dividends+323.6%+217.0%
CAGR (3Y)Annualised 3-year return-13.8%-7.7%
UNH leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MOH and UNH each lead in 1 of 2 comparable metrics.

MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 88.8% from its 52-week high vs MOH's 57.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMOH logoMOHMolina Healthcare…UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 500-0.04x0.59x
52-Week HighHighest price in past year$333.00$409.70
52-Week LowLowest price in past year$121.06$234.60
% of 52W HighCurrent price vs 52-week peak+57.7%+88.8%
RSI (14)Momentum oscillator 0–10079.683.3
Avg Volume (50D)Average daily shares traded1.4M8.1M
Evenly matched — MOH and UNH each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates MOH as "Buy" and UNH as "Buy". Consensus price targets imply 5.9% upside for UNH (target: $385) vs -13.6% for MOH (target: $166). UNH is the only dividend payer here at 2.39% yield — a key consideration for income-focused portfolios.

MetricMOH logoMOHMolina Healthcare…UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$166.09$385.43
# AnalystsCovering analysts3852
Dividend YieldAnnual dividend ÷ price+2.4%
Dividend StreakConsecutive years of raises25
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap+10.0%+1.7%
Insufficient data to determine a leader in this category.
Key Takeaway

UNH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MOH leads in 1 (Valuation Metrics). 1 tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 3 of 6 categories
Loading custom metrics...

MOH vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is MOH or UNH a better buy right now?

For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.

8% revenue growth year-over-year, versus 11. 7% for Molina Healthcare, Inc. (MOH). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (37. 3x forward), making it the more compelling value choice. Analysts rate Molina Healthcare, Inc. (MOH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MOH or UNH?

On trailing P/E, Molina Healthcare, Inc.

(MOH) is the cheapest at 21. 5x versus UnitedHealth Group Incorporated at 27. 5x. On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 19. 9x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — MOH or UNH?

Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.

8%, compared to -26. 9% for Molina Healthcare, Inc. (MOH). Over 10 years, the gap is even starker: MOH returned +323. 6% versus UNH's +217. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MOH or UNH?

By beta (market sensitivity over 5 years), Molina Healthcare, Inc.

(MOH) is the lower-risk stock at -0. 04β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately -1702% more volatile than MOH relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 97% for Molina Healthcare, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MOH or UNH?

By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.

8% versus 11. 7% for Molina Healthcare, Inc. (MOH). On earnings-per-share growth, the picture is similar: UnitedHealth Group Incorporated grew EPS -14. 7% year-over-year, compared to -56. 3% for Molina Healthcare, Inc.. Over a 3-year CAGR, MOH leads at 12. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MOH or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus 1. 0% for Molina Healthcare, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 1. 7% for MOH. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MOH or UNH more undervalued right now?

On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 19.

9x forward P/E versus 37. 3x for Molina Healthcare, Inc. — 17. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 5. 9% to $385. 43.

08

Which pays a better dividend — MOH or UNH?

In this comparison, UNH (2.

4% yield) pays a dividend. MOH does not pay a meaningful dividend and should not be held primarily for income.

09

Is MOH or UNH better for a retirement portfolio?

For long-horizon retirement investors, Molina Healthcare, Inc.

(MOH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), +323. 6% 10Y return). Both have compounded well over 10 years (MOH: +323. 6%, UNH: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MOH and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

UNH pays a dividend while MOH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MOH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MOH and UNH on the metrics below

Revenue Growth>
%
(MOH: -3.1% · UNH: 2.0%)
P/E Ratio<
x
(MOH: 21.5x · UNH: 27.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.